Filed before 2025Filed 9 January 2020
Amplyx Pharmaceuticals, Inc. has sold $91.3M so far
Amplyx Pharmaceuticals, Inc., a pharmaceuticals company based in San Diego, CA, has sold $91.3M so far in its equity round, according to a filing dated 9 January 2020.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 9 January 2020
- First filed
- 1 August 2017
- Round
- Equity round (amended filing)
- Amount sold
- $91.3M
- Offering size
- $103M
- Investors so far
- 28
- Based in
- San Diego, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
3 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 94% of the 1,744 tracked raises with an amount filed in 2020, and than 95% of the 40 in pharmaceuticals.
Amplyx Pharmaceuticals, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 9 Jan 2020 | Amended filing | $91.3M | This raise |
| 1 Aug 2017 | New filing | $40M | This raise |
| 24 Dec 2015 | Amended filing | $23.7M | Another raise |
| 12 Nov 2015 | New filing | $20M | Another raise |
More with NEA on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.